This is a preview of subscription content, log in via an institution to check access.
Reference
Nannini S, et al. Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort. Current Oncology 31: 1656-1666, No. 3, Mar 2024. Available from: URL: https://dx.doi.org/10.3390/curroncol31030126
Rights and permissions
About this article
Cite this article
Pembrolizumab. Reactions Weekly 2007, 290 (2024). https://doi.org/10.1007/s40278-024-58850-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-58850-7